| Literature DB >> 33708464 |
Chandra Sekhar Kathera1, Jiang Longwei2, Avilala Janardhan1, Lihong Qin3, Qi Zhang4, Wu Lan2, Jia Shaochang2, Zhigang Guo1.
Abstract
Lung cancer is one of the leading causes of cancer deaths worldwide and existing approaches are not enough to manage, and hence, it is important to concentrate on new drug strategies. This study was aimed to identify the interacting partner of Flap endonuclease 1 (FEN1) and its role in cancer treatment. We identified a new FEN1 interacting partner confirmed it as Heat Shock Protein 70 (HSP 70), and its effect on FEN1 expression, in vitro. Additionally, we found that the 5-Fluorouracil's (5-FU) function was significantly improved when used in combination with HSP 70 inhibitor (KNK 437). The findings are interesting, elucidating the synergistic mechanism between two compounds which helps to develop a novel management strategy for over-expressed FEN1 in the lung. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-020-02598-3. © King Abdulaziz City for Science and Technology 2021.Entities:
Keywords: Cancer treatment; Flap endo nuclease-1; Heat shock protein 70; Inhibitor compound; KNK437; Protein interaction
Year: 2021 PMID: 33708464 PMCID: PMC7907298 DOI: 10.1007/s13205-020-02598-3
Source DB: PubMed Journal: 3 Biotech ISSN: 2190-5738 Impact factor: 2.406